Health AstraZeneca Pays $185M to Add Oral GLP-1 Drug Candidate to Pipeline January 17, 2024 58 TelecomApril 25, 2025Airtel International Roaming Plan With Access to Data in India and 189 Countries Launched TelecomApril 23, 2025Indian Telecom Operators May Hike Tariffs by December 2025 As Part of Tariff Repair Efforts: Report TelecomApril 18, 2025Vodafone Idea (Vi) Silently Rolls Out Rs. 340 Recharge Plan With 1GB Daily Data, 28-Day Validity TelecomApril 17, 2025Airtel Launches Rs. 451 Prepaid Recharge Plan With Complimentary JioHotstar Subscription: Benefits TelecomApril 16, 2025Airtel Partners With Blinkit for 10-Minute Home Delivery of SIM Cards in Select Indian Cities AstraZeneca gains global rights to an oral GLP-1 agonist on track to reach Phase 2 testing in 2024. Under China-based Eccogene, the small molecule’s Phase 1 data show reductions in glucose and body weight. Prime Plus Facebook Twitter Pinterest WhatsApp SportsApril 28, 2025RCB win 6 away games after decade, can they become first team to register perfect 7? Sports WATCH: Virat Kohli mocks KL Rahul with “Kantara celebration” after RCB’s win April 28, 2025 Sports BGIS 2025 LAN Day 2: GODLIKE Closes in on the Lead with Stunning Performance April 26, 2025 Sports BGIS 2025 Grand Finals Day 3: Teams, Match Schedule, and Stream April 26, 2025
